Penston J G, Wormsley K G
Ninewells Hospital and Medical School, Dundee, UK.
Aliment Pharmacol Ther. 1990 Dec;4(6):569-76. doi: 10.1111/j.1365-2036.1990.tb00504.x.
Fifty-seven patients who developed asymptomatic recurrence of duodenal ulceration during maintenance treatment with ranitidine were followed up to assess the risk of developing symptoms or complications of ulcer disease. The risk of development of symptomatic ulcer recurrence was 4% in the first year of follow-up during continuous maintenance treatment, irrespective of whether or not the asymptomatic ulcer had been actively treated (by doubling the dose of ranitidine used for maintenance therapy). The asymptomatic duodenal ulceration during maintenance treatment did not predispose to complications such as haemorrhage or perforation. It seems, therefore, that patients receiving maintenance treatment for duodenal ulceration do not require endoscopic re-examination unless symptoms have recurred, because the asymptomatic recurrences of duodenal ulceration occurring during maintenance treatment are clinically benign, usually heal spontaneously if maintenance treatment is continued, and do not require active medical intervention.
57例在使用雷尼替丁维持治疗期间出现十二指肠溃疡无症状复发的患者接受了随访,以评估出现溃疡疾病症状或并发症的风险。在持续维持治疗的随访第一年,有症状的溃疡复发风险为4%,无论无症状溃疡是否接受了积极治疗(通过将用于维持治疗的雷尼替丁剂量加倍)。维持治疗期间的无症状十二指肠溃疡不会引发诸如出血或穿孔等并发症。因此,似乎十二指肠溃疡维持治疗的患者除非症状复发,否则不需要内镜复查,因为维持治疗期间发生的十二指肠溃疡无症状复发在临床上是良性的,如果继续维持治疗通常会自愈,且不需要积极的医学干预。